Menu
GeneBe

ANKS1B

ankyrin repeat and sterile alpha motif domain containing 1B, the group of Ankyrin repeat domain containing|Sterile alpha motif domain containing

Basic information

Region (hg38): 12:98726456-99984936

Links

ENSG00000185046NCBI:56899OMIM:607815HGNC:24600Uniprot:Q7Z6G8AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • complex neurodevelopmental disorder (Limited), mode of inheritance: AD
  • complex neurodevelopmental disorder (Moderate), mode of inheritance: AD

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ANKS1B gene.

  • Inborn genetic diseases (34 variants)
  • not provided (23 variants)
  • Normal pregnancy (1 variants)
  • not specified (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ANKS1B gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
5
clinvar
5
clinvar
10
missense
30
clinvar
4
clinvar
2
clinvar
36
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
2
splice region
0
non coding
4
clinvar
2
clinvar
2
clinvar
8
Total 0 1 35 11 9

Variants in ANKS1B

This is a list of pathogenic ClinVar variants found in the ANKS1B region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-98727166-T-C APAF1-related disorder Likely benign (May 28, 2019)3041818
12-98732429-G-A not specified Uncertain significance (Dec 03, 2021)2263947
12-98732569-T-C APAF1-related disorder Benign (Jul 11, 2019)3042071
12-98735616-G-A Uncertain significance (Jun 06, 2021)1386926
12-98745774-C-T Likely benign (Jun 20, 2018)738742
12-98751357-C-T not specified Uncertain significance (Nov 13, 2023)3126990
12-98751398-G-C not specified Uncertain significance (Feb 26, 2024)3126989
12-98773176-T-C not specified Uncertain significance (Oct 04, 2022)2316839
12-98773181-T-C not specified Uncertain significance (Sep 27, 2022)1708480
12-98781115-A-G Likely pathogenic (Feb 19, 2020)1067469
12-98798993-T-C not specified Uncertain significance (Nov 12, 2021)2260885
12-98801071-C-T not specified Uncertain significance (Jun 01, 2023)2525660
12-98801073-G-A not specified Uncertain significance (Oct 12, 2022)2318272
12-98829259-A-C not specified Uncertain significance (Oct 13, 2021)2255319
12-98829260-T-C not specified Uncertain significance (Jan 19, 2024)3126988
12-98829332-G-A not specified Uncertain significance (May 26, 2022)2225136
12-98832070-C-T not specified Uncertain significance (Aug 15, 2023)2613135
12-99053161-A-G not specified Uncertain significance (Nov 13, 2023)3126987
12-99053272-G-A not specified Uncertain significance (Nov 15, 2023)3126986
12-99084952-A-C not specified Uncertain significance (Sep 14, 2022)2228045
12-99084970-A-G Likely benign (Dec 31, 2019)746071
12-99085016-T-C not specified Uncertain significance (May 23, 2023)2549976
12-99154346-C-T Benign (Dec 31, 2019)717156
12-99154454-G-A Benign (Dec 31, 2019)737272
12-99244388-A-C not specified Uncertain significance (Jun 18, 2021)2232936

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ANKS1Bprotein_codingprotein_codingENST00000547776 261258198
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.000.00002181246240111246350.0000441
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.954326420.6730.00003208139
Missense in Polyphen74193.060.383292446
Synonymous0.2922392450.9760.00001342416
Loss of Function6.41761.10.1150.00000317774

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001190.000119
Ashkenazi Jewish0.0002000.000199
East Asian0.000.00
Finnish0.00004650.0000464
European (Non-Finnish)0.00002770.0000265
Middle Eastern0.000.00
South Asian0.000.00
Other0.0001650.000165

dbNSFP

Source: dbNSFP

Function
FUNCTION: Isoform 2 may participate in the regulation of nucleoplasmic coilin protein interactions in neuronal and transformed cells.; FUNCTION: Isoform 4 may play a role as a modulator of APP processing. Overexpression can down-regulate APP processing.;
Pathway
Ectoderm Differentiation (Consensus)

Recessive Scores

pRec
0.210

Intolerance Scores

loftool
0.269
rvis_EVS
-1.22
rvis_percentile_EVS
5.67

Haploinsufficiency Scores

pHI
0.212
hipred
Y
hipred_score
0.508
ghis
0.584

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.595

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Anks1b
Phenotype
skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);

Gene ontology

Biological process
regulation of synaptic plasticity by receptor localization to synapse
Cellular component
cytosol;plasma membrane;postsynaptic density;Cajal body;cell junction;dendritic spine;intracellular membrane-bounded organelle;postsynaptic membrane
Molecular function
ephrin receptor binding